Concepedia

John Brognard

JB

Statistics

Publications

33

Citations

5.4K

H-Index

28

Active since

2001

Affiliations

National Cancer Institute(Current)

Cancer Research UK Manchester Institute

University of Manchester

Center for Cancer Research

University of California San Diego

John Brognard is an author at National Cancer Institute specializing in life sciences, signal transduction, and oncology.

ORCID

Publications per year

2001–2023

33

Publications

33

Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation.

John Brognard, Amy S. Clark, Yucheng Ni et al. · PubMed · 2001 · 892 citations

, , +17

PHLPP and a Second Isoform, PHLPP2, Differentially Attenuate the Amplitude of Akt Signaling by Regulating Distinct Akt Isoforms

John Brognard, Emma Sierecki, Tianyan Gao et al. · Molecular Cell · 2007 · 578 citations · Full text

, , +14

Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells

Kip A. West, John Brognard, Amy S. Clark et al. · Journal of Clinical Investigation · 2003 · 512 citations · Full text

, , +16

Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells

Kip A. West, John Brognard, Amy S. Clark et al. · Journal of Clinical Investigation · 2003 · 501 citations · Full text

, , +16

Cancer-Associated Protein Kinase C Mutations Reveal Kinase’s Role as Tumor Suppressor

Corina E. Antal, Andrew Hudson, Emily L. Kang et al. · Cell · 2015 · 334 citations · Full text

, , +12

1–5 of 33